RBC Capital lowered the firm’s price target on Universal Health (UHS) to $190 from $216 and keeps a Sector Perform rating on the shares. The company’s Q1 results came in slightly ahead of expectations, but RBC believes Tuesday’s 9.5% pullback in shares reflects investor concern over its ability to achieve core growth acceleration through the balance of the year to get to the midpoint of the reaffirmed earnings outlook, the analyst tells investors in a research note. The print also reinforces the recent rotation into managed care, which should persist through the first half of the year, the firm added.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on UHS:
- Universal Health price target lowered to $204 from $241 at Baird
- Universal Health downgraded to Market Perform from Outperform at Raymond James
- Universal Health Services Earnings Call Highlights Growth
- Universal Health Maintained at Hold as Q1 Beat Driven by Pricing Strength but Volume Trends Remain Soft
- Analyst Reiterates Sell on Universal Health as Policy Risks Offset Q1 Beat; Price Target Maintained at $215
